Doximity (NYSE: DOCS) reported Q1 FY2027 results with revenue of $156.6 million, up 7% year-over-year. While revenue continued to grow, profitability declined as net income, adjusted EBITDA, operating cash flow, and free cash flow all decreased from the prior year. The company also provided guidance for Q2 FY2027 ending September 30, 2026. Sector: Healthcare Technology Key Highlights 💰 Revenue: $156.6 million (+7% YoY) 📉 Net income: $24.3 million vs. $53.3 million last year 📊 Adjusted EBITDA: $74.8 million (-6% YoY) 💵 Operating cash flow: -32% YoY; Free cash flow: -34% YoY 📅 Issued guidance for Q2 FY2027 Why It Matters While Doximity continued to deliver revenue growth, weaker profitability and declining cash flow highlight margin pressures, making upcoming quarters and execution against guidance important for investors. Read More: https://www.thinksabio.com/reports/isr/DOCS